Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 94Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Bristol-Myers Squibb Canada

02 4Gowling Lafleur Henderson LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2279198

Filing Date : 1998-02-02

Strength per Unit : 200 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-02

Date Granted : 2009-04-14

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2279198

Filing Date : 1998-02-02

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-02

Date Granted : 2009-04-14

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2332876

Filing Date : 1999-05-24

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-05-24

Date Granted : 2008-07-08

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2279198

Filing Date : 1998-02-02

Strength per Unit : 600mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-02

Date Granted : 2009-04-14

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2332876

Filing Date : 1999-05-24

Strength per Unit : 600mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-05-24

Date Granted : 2008-07-08

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2279198

Filing Date : 1998-02-02

Strength per Unit : 50 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-02

Date Granted : 2009-04-14

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2101572

Filing Date : 1993-07-29

Strength per Unit : 50 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-29

Date Granted : 2001-08-28

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2101572

Filing Date : 1993-07-29

Strength per Unit : 200 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-29

Date Granted : 2001-08-28

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2101572

Filing Date : 1993-07-29

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-29

Date Granted : 2001-08-28

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Efavirenz

Brand Name : SUSTIVA

Patent Number : 2101572

Filing Date : 1993-07-29

Strength per Unit : 600mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-29

Date Granted : 2001-08-28

blank